Larry Kociolek to Infant
This is a "connection" page, showing publications Larry Kociolek has written about Infant.
Connection Strength
1.768
-
Clostridioides difficile in Children. Infect Dis Clin North Am. 2025 Dec; 39(4):709-725.
Score: 0.137
-
Comparison of Upper Respiratory Viral Load Distributions in Asymptomatic and Symptomatic Children Diagnosed with SARS-CoV-2 Infection in Pediatric Hospital Testing Programs. J Clin Microbiol. 2020 12 17; 59(1).
Score: 0.099
-
Severe Acute Respiratory Syndrome Coronavirus 2 Point Prevalence Among Asymptomatic Hospitalized Children and Subsequent Healthcare Worker Evaluation. J Pediatric Infect Dis Soc. 2020 Nov 10; 9(5):617-619.
Score: 0.098
-
Age-Related Differences in Nasopharyngeal Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Levels in Patients With Mild to Moderate Coronavirus Disease 2019 (COVID-19). JAMA Pediatr. 2020 09 01; 174(9):902-903.
Score: 0.097
-
SARS-CoV-2 Infection in Infants Less than 90 Days Old. J Pediatr. 2020 Sep; 224:150-152.
Score: 0.096
-
Natural Clostridioides difficile Toxin Immunization in Colonized Infants. Clin Infect Dis. 2020 05 06; 70(10):2095-2102.
Score: 0.095
-
Clostridioides difficile Whole-Genome Sequencing Reveals Limited Within-Host Genetic Diversity in a Pediatric Cohort. J Clin Microbiol. 2019 09; 57(9).
Score: 0.091
-
Risk factors for Clostridioides (Clostridium) difficile infection following solid organ transplantation in children. Transpl Infect Dis. 2019 Oct; 21(5):e13149.
Score: 0.090
-
Healthcare provider diagnostic testing practices for identification of Clostridioides (Clostridium) difficile in children: an Emerging Infections Network survey. Infect Control Hosp Epidemiol. 2019 03; 40(3):276-280.
Score: 0.087
-
Whole-genome analysis reveals the evolution and transmission of an MDR DH/NAP11/106 Clostridium difficile clone in a paediatric hospital. J Antimicrob Chemother. 2018 05 01; 73(5):1222-1229.
Score: 0.083
-
Differences in the Molecular Epidemiology and Antibiotic Susceptibility of Clostridium difficile Isolates in Pediatric and Adult Patients. Antimicrob Agents Chemother. 2016 08; 60(8):4896-900.
Score: 0.073
-
Clinical and Microbiologic Assessment of Cases of Pediatric Community-associated Clostridium difficile Infection Reveals Opportunities for Improved Testing Decisions. Pediatr Infect Dis J. 2016 Feb; 35(2):157-61.
Score: 0.071
-
Risk Factors for Recurrent Clostridium difficile Infection in Children: A Nested Case-Control Study. J Pediatr. 2015 Aug; 167(2):384-9.
Score: 0.067
-
Molecular epidemiology of Clostridium difficile infections in children: a retrospective cohort study. Infect Control Hosp Epidemiol. 2015 Apr; 36(4):445-51.
Score: 0.067
-
Concomitant Medical Conditions and Therapies Preclude Accurate Classification of Children With Severe or Severe Complicated Clostridium difficile Infection. J Pediatric Infect Dis Soc. 2015 Dec; 4(4):e139-42.
Score: 0.066
-
Is pediatric Clostridium difficile infection associated with prior antibiotic exposure? Future Microbiol. 2014; 9(7):825-8.
Score: 0.061
-
National variability in surveillance, testing, and infection prevention for Clostridium difficile infection in pediatric populations. Am J Infect Control. 2013 Oct; 41(10):933-5.
Score: 0.059
-
Scheffersomyces spartinae Fungemia among Pediatric Patients, Pakistan, 2020-2024. Emerg Infect Dis. 2025 Aug; 31(8):1550-1560.
Score: 0.034
-
Bacteremia in Pediatric Solid Organ Transplant Recipients within 1 Year of Transplant. Transpl Infect Dis. 2025 Jul-Aug; 27(4):e70030.
Score: 0.033
-
Outcomes Associated with Healthcare-Associated Respiratory Syncytial Virus in Children's Hospitals. J Pediatric Infect Dis Soc. 2024 Nov 27; 13(11):594-598.
Score: 0.033
-
Healthcare-Associated Respiratory Syncytial Virus in Children's Hospitals. J Pediatric Infect Dis Soc. 2023 May 31; 12(5):265-272.
Score: 0.029
-
Factors Associated With Severe Illness in Patients Aged <21 Years Hospitalized for COVID-19. Hosp Pediatr. 2022 09 01; 12(9):760-783.
Score: 0.028
-
Clostridioides difficile Infection in Hospitalized Pediatric Patients: Comparisons of Epidemiology, Testing, and Treatment from 2013 to 2019. J Pediatr. 2023 01; 252:111-116.e1.
Score: 0.028
-
Characteristics and Clinical Outcomes of Children and Adolescents Aged <18 Years Hospitalized with COVID-19 - Six Hospitals, United States, July-August 2021. MMWR Morb Mortal Wkly Rep. 2021 12 31; 70(5152):1766-1772.
Score: 0.027
-
Neuroimaging manifestations in children with SARS-CoV-2 infection: a multinational, multicentre collaborative study. Lancet Child Adolesc Health. 2021 03; 5(3):167-177.
Score: 0.025
-
Ideal and Actual Impact of Rapid Diagnostic Testing and Antibiotic Stewardship on Antibiotic Prescribing and Clinical Outcomes in Children With Positive Blood Cultures. Pediatr Infect Dis J. 2019 02; 38(2):131-137.
Score: 0.022
-
Utilizing the electronic health record to construct antibiograms for previously healthy children with urinary tract infections. Infect Control Hosp Epidemiol. 2018 12; 39(12):1473-1475.
Score: 0.021
-
Safety and Pharmacokinetic Study of Fidaxomicin in Children With Clostridium difficile-Associated Diarrhea: A Phase 2a Multicenter Clinical Trial. J Pediatric Infect Dis Soc. 2018 Aug 17; 7(3):210-218.
Score: 0.021
-
Clostridium difficile-Diagnostic and Clinical Challenges. Clin Chem. 2016 Feb; 62(2):310-4.
Score: 0.018
-
P450c17 deficiency caused by compound heterozygosity for two novel mutations presenting as hypotension in early infancy. Horm Res Paediatr. 2011; 76(6):434-41.
Score: 0.013